Tarsus Pharmaceuticals (TARS) Profit After Tax Growth (3y) (2022 - 2026)
Tarsus Pharmaceuticals (TARS) Profit After Tax Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 9.53% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 38.43% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 13.80% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -27.65% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 70.25% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Tarsus Pharmaceuticals | 2.58 Bn | 2.48 Bn | 152.66 Mn | 31.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.14% |
| Dec 31, 2025 | 15.77% |
| Sep 30, 2025 | 18.18% |
| Jun 30, 2025 | -52.43% |
| Mar 31, 2025 | -7.60% |
| Dec 31, 2024 | -15.58% |
| Sep 30, 2024 | -14.27% |
| Jun 30, 2024 | -93.51% |
| Mar 31, 2024 | -75.91% |
| Dec 31, 2023 | -53.94% |
| Sep 30, 2023 | -56.87% |
| Jun 30, 2023 | -113.04% |
| Mar 31, 2023 | -128.73% |
| Dec 31, 2022 | -113.15% |
| Sep 30, 2022 | -220.98% |